Page last updated: 2024-08-17

triaziquone and Lymphangioendothelioma, Malignant

triaziquone has been researched along with Lymphangioendothelioma, Malignant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adler, S; Case, RW; Helm, F; Holtermann, OA; Klein, E; Milgrom, H; Murphy, GP; Prior, RL; Rosner, D; Stoll, HL1

Reviews

1 review(s) available for triaziquone and Lymphangioendothelioma, Malignant

ArticleYear
Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.
    Transplantation proceedings, 1975, Volume: 7, Issue:2

    Topics: Antigens, Bacterial; Antigens, Fungal; Antigens, Viral; Breast Neoplasms; Carcinoma, Basal Cell; Female; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphangiosarcoma; Lymphoma, Large B-Cell, Diffuse; Melanoma; Neoplasms, Multiple Primary; Nitrobenzenes; Precancerous Conditions; Skin Neoplasms; Skin Tests; Triaziquone; Vulvar Neoplasms

1975